{"id":27883,"date":"2020-07-12T06:09:46","date_gmt":"2020-07-12T06:09:46","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=27883"},"modified":"2023-08-09T09:50:22","modified_gmt":"2023-08-09T09:50:22","slug":"krabbes-disease","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/krabbes-disease\/","title":{"rendered":"Krabbe\u2019s disease"},"content":{"rendered":"<p>A rare genetic disorder (also known as leukodystrophy) consisting of a deficiency of the enzyme beta-galactosidase, which causes the myelin sheath surrounding nerves in the brain to degenerate. The disorder is characterized by progressive intellectual disability, paralysis, blindness, deafness, and pseudobulbar palsy.<\/p>\n<hr \/>\n<p>Krabbe disease is a rare, degenerative disorder of the central and peripheral nervous systems. It is one of a group of genetic disorders called the leukodystrophies. The disorder involves a genetic anomaly that interferes with the development of nerves in the brain, and particularly with the development of the myelin sheath that surrounds the nerve. It is identified by the presence of characteristic globoid cells in the brain tissue. Krabbe disease is inherited in an autosomal recessive pattern and occurs equally as often in boys and girls. The gene involved has been identified as 14q31. If more than one person in a family is diagnosed with Krabbe disease, they may not have the same form or express the same symptoms.<\/p>\n<hr \/>\n<p>Globoid cell leukodystrophy due to the accumulation of galactocerebroside in the tissues, resulting from a deficiency of galactocerebrosidase. Clinically, affected infants develop seizures, deafness, blindness, cachexia, paralysis, and marked mental deficiency. Survival beyond 2 years is rare.<\/p>\n<hr \/>\n<div class=\"group w-full text-token-text-primary border-b border-black\/10 dark:border-gray-900\/50 bg-gray-50 dark:bg-[#444654]\">\n<div class=\"flex p-4 gap-4 text-base md:gap-6 md:max-w-2xl lg:max-w-[38rem] xl:max-w-3xl md:py-6 lg:px-0 m-auto\">\n<div class=\"relative flex w-[calc(100%-50px)] flex-col gap-1 md:gap-3 lg:w-[calc(100%-115px)]\">\n<div class=\"flex flex-grow flex-col gap-3\">\n<div class=\"min-h-[20px] flex flex-col items-start gap-3 overflow-x-auto whitespace-pre-wrap break-words\">\n<div class=\"markdown prose w-full break-words dark:prose-invert light AIPRM__conversation__response\">\n<p>Krabbe&#8217;s disease is a rare genetic metabolic disorder that typically leads to early childhood fatality. It stems from a lack of the enzyme galactocerebrosidase, causing toxic chemicals to build up in the nervous system cells. Symptoms, such as seizures, vision loss, deafness, and muscle weakness, generally start to appear by nine months.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>A rare genetic disorder (also known as leukodystrophy) consisting of a deficiency of the enzyme beta-galactosidase, which causes the myelin sheath surrounding nerves in the brain to degenerate. The disorder is characterized by progressive intellectual disability, paralysis, blindness, deafness, and pseudobulbar palsy. Krabbe disease is a rare, degenerative disorder of the central and peripheral nervous [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-27883","post","type-post","status-publish","format-standard","hentry","category-k"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Krabbe\u2019s disease - Definition of Krabbe\u2019s disease<\/title>\n<meta name=\"description\" content=\"A rare genetic disorder (also known as leukodystrophy) consisting of a deficiency of the enzyme beta-galactosidase, which causes the myelin sheath surrounding nerves in the brain to degenerate. The disorder is characterized by progressive intellectual disability, paralysis, blindness, deafness, and pseudobulbar palsy.Krabbe disease is a rare, degenerative disorder of the central and peripheral nervous systems. It is one of a group of genetic disorders called the leukodystrophies. The disorder involves a genetic anomaly that interferes with the development of nerves in the brain, and particularly with the development of the myelin sheath that surrounds the nerve. It is identified by the presence of characteristic globoid cells in the brain tissue. Krabbe disease is inherited in an autosomal recessive pattern and occurs equally as often in boys and girls. The gene involved has been identified as 14q31. If more than one person in a family is diagnosed with Krabbe disease, they may not have the same form or express the same symptoms.Globoid cell leukodystrophy due to the accumulation of galactocerebroside in the tissues, resulting from a deficiency of galactocerebrosidase. Clinically, affected infants develop seizures, deafness, blindness, cachexia, paralysis, and marked mental deficiency. Survival beyond 2 years is rare.Krabbe&#039;s disease is a rare genetic metabolic disorder that typically leads to early childhood fatality. It stems from a lack of the enzyme galactocerebrosidase, causing toxic chemicals to build up in the nervous system cells. Symptoms, such as seizures, vision loss, deafness, and muscle weakness, generally start to appear by nine months.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/krabbes-disease\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Krabbe\u2019s disease - Definition of Krabbe\u2019s disease\" \/>\n<meta property=\"og:description\" content=\"A rare genetic disorder (also known as leukodystrophy) consisting of a deficiency of the enzyme beta-galactosidase, which causes the myelin sheath surrounding nerves in the brain to degenerate. The disorder is characterized by progressive intellectual disability, paralysis, blindness, deafness, and pseudobulbar palsy.Krabbe disease is a rare, degenerative disorder of the central and peripheral nervous systems. It is one of a group of genetic disorders called the leukodystrophies. The disorder involves a genetic anomaly that interferes with the development of nerves in the brain, and particularly with the development of the myelin sheath that surrounds the nerve. It is identified by the presence of characteristic globoid cells in the brain tissue. Krabbe disease is inherited in an autosomal recessive pattern and occurs equally as often in boys and girls. The gene involved has been identified as 14q31. If more than one person in a family is diagnosed with Krabbe disease, they may not have the same form or express the same symptoms.Globoid cell leukodystrophy due to the accumulation of galactocerebroside in the tissues, resulting from a deficiency of galactocerebrosidase. Clinically, affected infants develop seizures, deafness, blindness, cachexia, paralysis, and marked mental deficiency. Survival beyond 2 years is rare.Krabbe&#039;s disease is a rare genetic metabolic disorder that typically leads to early childhood fatality. It stems from a lack of the enzyme galactocerebrosidase, causing toxic chemicals to build up in the nervous system cells. Symptoms, such as seizures, vision loss, deafness, and muscle weakness, generally start to appear by nine months.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/krabbes-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-12T06:09:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-09T09:50:22+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/krabbes-disease\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/krabbes-disease\/\",\"name\":\"Krabbe\u2019s disease - Definition of Krabbe\u2019s disease\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2020-07-12T06:09:46+00:00\",\"dateModified\":\"2023-08-09T09:50:22+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A rare genetic disorder (also known as leukodystrophy) consisting of a deficiency of the enzyme beta-galactosidase, which causes the myelin sheath surrounding nerves in the brain to degenerate. The disorder is characterized by progressive intellectual disability, paralysis, blindness, deafness, and pseudobulbar palsy.Krabbe disease is a rare, degenerative disorder of the central and peripheral nervous systems. It is one of a group of genetic disorders called the leukodystrophies. The disorder involves a genetic anomaly that interferes with the development of nerves in the brain, and particularly with the development of the myelin sheath that surrounds the nerve. It is identified by the presence of characteristic globoid cells in the brain tissue. Krabbe disease is inherited in an autosomal recessive pattern and occurs equally as often in boys and girls. The gene involved has been identified as 14q31. If more than one person in a family is diagnosed with Krabbe disease, they may not have the same form or express the same symptoms.Globoid cell leukodystrophy due to the accumulation of galactocerebroside in the tissues, resulting from a deficiency of galactocerebrosidase. Clinically, affected infants develop seizures, deafness, blindness, cachexia, paralysis, and marked mental deficiency. Survival beyond 2 years is rare.Krabbe's disease is a rare genetic metabolic disorder that typically leads to early childhood fatality. It stems from a lack of the enzyme galactocerebrosidase, causing toxic chemicals to build up in the nervous system cells. Symptoms, such as seizures, vision loss, deafness, and muscle weakness, generally start to appear by nine months.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/krabbes-disease\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/krabbes-disease\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/krabbes-disease\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Krabbe\u2019s disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Krabbe\u2019s disease - Definition of Krabbe\u2019s disease","description":"A rare genetic disorder (also known as leukodystrophy) consisting of a deficiency of the enzyme beta-galactosidase, which causes the myelin sheath surrounding nerves in the brain to degenerate. The disorder is characterized by progressive intellectual disability, paralysis, blindness, deafness, and pseudobulbar palsy.Krabbe disease is a rare, degenerative disorder of the central and peripheral nervous systems. It is one of a group of genetic disorders called the leukodystrophies. The disorder involves a genetic anomaly that interferes with the development of nerves in the brain, and particularly with the development of the myelin sheath that surrounds the nerve. It is identified by the presence of characteristic globoid cells in the brain tissue. Krabbe disease is inherited in an autosomal recessive pattern and occurs equally as often in boys and girls. The gene involved has been identified as 14q31. If more than one person in a family is diagnosed with Krabbe disease, they may not have the same form or express the same symptoms.Globoid cell leukodystrophy due to the accumulation of galactocerebroside in the tissues, resulting from a deficiency of galactocerebrosidase. Clinically, affected infants develop seizures, deafness, blindness, cachexia, paralysis, and marked mental deficiency. Survival beyond 2 years is rare.Krabbe's disease is a rare genetic metabolic disorder that typically leads to early childhood fatality. It stems from a lack of the enzyme galactocerebrosidase, causing toxic chemicals to build up in the nervous system cells. Symptoms, such as seizures, vision loss, deafness, and muscle weakness, generally start to appear by nine months.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/krabbes-disease\/","og_locale":"en_US","og_type":"article","og_title":"Krabbe\u2019s disease - Definition of Krabbe\u2019s disease","og_description":"A rare genetic disorder (also known as leukodystrophy) consisting of a deficiency of the enzyme beta-galactosidase, which causes the myelin sheath surrounding nerves in the brain to degenerate. The disorder is characterized by progressive intellectual disability, paralysis, blindness, deafness, and pseudobulbar palsy.Krabbe disease is a rare, degenerative disorder of the central and peripheral nervous systems. It is one of a group of genetic disorders called the leukodystrophies. The disorder involves a genetic anomaly that interferes with the development of nerves in the brain, and particularly with the development of the myelin sheath that surrounds the nerve. It is identified by the presence of characteristic globoid cells in the brain tissue. Krabbe disease is inherited in an autosomal recessive pattern and occurs equally as often in boys and girls. The gene involved has been identified as 14q31. If more than one person in a family is diagnosed with Krabbe disease, they may not have the same form or express the same symptoms.Globoid cell leukodystrophy due to the accumulation of galactocerebroside in the tissues, resulting from a deficiency of galactocerebrosidase. Clinically, affected infants develop seizures, deafness, blindness, cachexia, paralysis, and marked mental deficiency. Survival beyond 2 years is rare.Krabbe's disease is a rare genetic metabolic disorder that typically leads to early childhood fatality. It stems from a lack of the enzyme galactocerebrosidase, causing toxic chemicals to build up in the nervous system cells. Symptoms, such as seizures, vision loss, deafness, and muscle weakness, generally start to appear by nine months.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/krabbes-disease\/","og_site_name":"Glossary","article_published_time":"2020-07-12T06:09:46+00:00","article_modified_time":"2023-08-09T09:50:22+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/krabbes-disease\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/krabbes-disease\/","name":"Krabbe\u2019s disease - Definition of Krabbe\u2019s disease","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2020-07-12T06:09:46+00:00","dateModified":"2023-08-09T09:50:22+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A rare genetic disorder (also known as leukodystrophy) consisting of a deficiency of the enzyme beta-galactosidase, which causes the myelin sheath surrounding nerves in the brain to degenerate. The disorder is characterized by progressive intellectual disability, paralysis, blindness, deafness, and pseudobulbar palsy.Krabbe disease is a rare, degenerative disorder of the central and peripheral nervous systems. It is one of a group of genetic disorders called the leukodystrophies. The disorder involves a genetic anomaly that interferes with the development of nerves in the brain, and particularly with the development of the myelin sheath that surrounds the nerve. It is identified by the presence of characteristic globoid cells in the brain tissue. Krabbe disease is inherited in an autosomal recessive pattern and occurs equally as often in boys and girls. The gene involved has been identified as 14q31. If more than one person in a family is diagnosed with Krabbe disease, they may not have the same form or express the same symptoms.Globoid cell leukodystrophy due to the accumulation of galactocerebroside in the tissues, resulting from a deficiency of galactocerebrosidase. Clinically, affected infants develop seizures, deafness, blindness, cachexia, paralysis, and marked mental deficiency. Survival beyond 2 years is rare.Krabbe's disease is a rare genetic metabolic disorder that typically leads to early childhood fatality. It stems from a lack of the enzyme galactocerebrosidase, causing toxic chemicals to build up in the nervous system cells. Symptoms, such as seizures, vision loss, deafness, and muscle weakness, generally start to appear by nine months.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/krabbes-disease\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/krabbes-disease\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/krabbes-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Krabbe\u2019s disease"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/27883","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=27883"}],"version-history":[{"count":5,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/27883\/revisions"}],"predecessor-version":[{"id":236394,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/27883\/revisions\/236394"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=27883"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=27883"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=27883"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}